First Detailed View of Molecular Structure May Usher in New Class of Cancer Drugs

User rating: 4.8 / 5 after 5 vote(s)

A side view of the receptor tyrosine kinase Kit in complex with stem cell factor (stem cell factor is colored in magenta). Credit: Yale University
A side view of the receptor tyrosine kinase Kit in complex with stem cell factor (stem cell factor is colored in magenta). Credit: Yale University

High resolution views of a receptor molecule that is implicated in cancer offer a clear target for the development of a new class of cancer drugs, Yale School of Medicine researchers report July 27 in Cell.


Full story »

All News summaries from General Science news
All News summaries for July 26, 2007